Stock Events

Stock Events

Cartesian Therapeutics (RNAC) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-10.5

-6.82

-3.14

0.54

Details

Expected EPS

-0.801667

Actual EPS

-1.13

Surprise EPS

-0.33

Surprise Percent

+40.96%

Description

Cartesian Therapeutics (RNAC) has reported earnings of -1.13 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.